The Review on Antimicrobial Resistance
Chaired by Jim O’Neill, March 2016
Much of the previous work to address the alarming rise of drug resistant infections has focussed on initiatives to re-invigorate the supply of new antimicrobial drugs. Success with coming up with new drugs will shift the ‘supply curve’ and solve the problem of antimicrobial resistance (AMR) for a period of time. However, shifting (and specifically reducing) the demand curve for antimicrobials provides a permanent solution to AMR over the longer term.